Emma Smith (Former)
1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
(
- Contribution to journal › Article
-
Mark
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
(
- Contribution to journal › Article
- 2021
-
Mark
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
(
- Contribution to journal › Article
- 2020
-
Mark
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
(
- Contribution to journal › Article
- 2019
-
Mark
PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia
(
- Contribution to journal › Article
- 2016
-
Mark
Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice
(
- Contribution to journal › Article
- 2014
-
Mark
A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse.
(
- Contribution to journal › Article
- 2008
-
Mark
Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets
(
- Contribution to journal › Article
- 2007
-
Mark
The CD53 and CEACAM-1 genes are genetic targets for early B cell factor.
(
- Contribution to journal › Article